Dr. Ziad Sayedahmad, MD

Dr. Sayedahmad practices at Dallas Regional Medical Center in Mesquite, Texas, part of Prime Healthcare Services.

Dr. Sayedahmad's NPI, 1679987481, was assigned on June 19, 2014. Dr. Sayedahmad graduated from University of Tichreen Faculty of Medicine in 2012. Dr. Sayedahmad holds California license A185202.

Dr. Sayedahmad's primary practice is Dallas Regional Medical Center, at 1011 North Galloway Avenue, Mesquite, TX 75149 in Dallas County. The practice phone is (214) 320-7000.

Dr. Sayedahmad's primary practice is Dallas Regional Medical Center in Mesquite, Texas, part of Prime Healthcare Services. Dr. Sayedahmad is also affiliated with Baylor University Medical Center. The medical group on file is Dallas Medical Physician Group. Dmand AI also links Dr. Sayedahmad to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sayedahmad practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sayedahmad's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Sayedahmad is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Sayedahmad's licenses on file in 4 states: California, Texas, Missouri and Michigan.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, chronic hypertension, coronary artery disease, heart valve disorders, high cholesterol and peripheral vascular disease among the conditions Dr. Sayedahmad treats.

CMS data shows 2,753 Medicare services from Dr. Sayedahmad across 27 procedure codes in 2024, for 1,413 Medicare patients. Medicare paid $132,529 for them.

CMS counts 1,413 Medicare patients who saw Dr. Sayedahmad in 2024. The largest group is 65 to 74, with 522 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sayedahmad's median patient age at 59, with 55% women.

In 2024, Dr. Sayedahmad wrote 719 Medicare Part D claims for 258 patients. 85% of them were for generic drugs. CMS names the drug for 598 of them, across 19 drugs with 11 or more claims each, at $70,204 in total drug cost. In 2023, CMS named 120 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Sayedahmad for performance year 2024, reported as part of a group. Dr. Sayedahmad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Sayedahmad, published from 2018 to 2020. 2018 was the busiest year, with 2. Dr. Sayedahmad's most frequent co-authors are Yasser Sa D Abdelrahman Al-Khadra, MD, M. Chadi Alraies, MD and Fahed Darmoch.

CMS Open Payments shows 150 general payments to Dr. Sayedahmad from 37 drug and device companies from 2017 to 2025. Grants make up the largest share, 52% of the total. Medtronic, Inc. paid the most, $8,105.

Dr. Sayedahmad graduated from University of Tichreen Faculty of Medicine in 2012.

Dr. Sayedahmad is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.